Fresenius Financials

FSNUY Stock  USD 8.71  0.05  0.58%   
You can utilize Fresenius SE fundamental data analysis to find out if markets are presently mispricing the company. We are able to break down and analyze data for thirty-four available fundamental indicators for Fresenius SE Co, which can be compared to its peers. The stock experiences a moderate upward volatility. Check odds of Fresenius to be traded at $9.58 in 90 days.
  
Understanding current and past Fresenius Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Fresenius' financial statements are interrelated, with each one affecting the others. For example, an increase in Fresenius' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Fresenius' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Fresenius SE Co. Check Fresenius' Beneish M Score to see the likelihood of Fresenius' management manipulating its earnings.

Fresenius Stock Summary

Fresenius competes with Medical Facilities, Ramsay Health, and Nova Leap. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Hhe, Germany. Fresenius operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 318647 people.
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
ISINUS35804M1053
Business AddressElse-Kroener-Strasse 1, Bad
SectorHealthcare
IndustryMedical Care Facilities
BenchmarkDow Jones Industrial
Websitewww.fresenius.com
Phone49 6172 608 2487
CurrencyUSD - US Dollar

Fresenius Key Financial Ratios

Fresenius' financial ratios allow both analysts and investors to convert raw data from Fresenius' financial statements into concise, actionable information that can be used to evaluate the performance of Fresenius over time and compare it to other companies across industries.

Fresenius Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Fresenius's current stock value. Our valuation model uses many indicators to compare Fresenius value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fresenius competition to find correlations between indicators driving Fresenius's intrinsic value. More Info.
Fresenius SE Co is rated # 2 in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers reporting about  0.37  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Fresenius SE Co is roughly  2.72 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Fresenius by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Fresenius' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Fresenius SE Systematic Risk

Fresenius' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Fresenius volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Fresenius SE correlated with the market. If Beta is less than 0 Fresenius generally moves in the opposite direction as compared to the market. If Fresenius Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Fresenius SE is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Fresenius is generally in the same direction as the market. If Beta > 1 Fresenius moves generally in the same direction as, but more than the movement of the benchmark.

Fresenius November 26, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Fresenius help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Fresenius SE Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Fresenius SE Co based on widely used predictive technical indicators. In general, we focus on analyzing Fresenius Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Fresenius's daily price indicators and compare them against related drivers.

Additional Tools for Fresenius Pink Sheet Analysis

When running Fresenius' price analysis, check to measure Fresenius' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius is operating at the current time. Most of Fresenius' value examination focuses on studying past and present price action to predict the probability of Fresenius' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius' price. Additionally, you may evaluate how the addition of Fresenius to your portfolios can decrease your overall portfolio volatility.